Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of CD8+ T Cell Activation on Live Attenuated Hepatitis A Vaccine in Obesity/Overweight Children and Young Adults
TCTR20210825005Phase 0Active, not recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Aug 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 0, single-arm trial of hepatitis A vaccine (live, attenuated) in hepatitis A (HAV), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: CD8+ T cell activation. Started Aug 2021; status: active, not recruiting.
02
Drugs
hepatitis A vaccine (live, attenuated)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on TCTR20210825005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210825005.